Industries > Pharma > Neuromodulation Devices: World Market Prospects 2013-2023
Neuromodulation Devices: World Market Prospects 2013-2023
Neuromodulation is one of the fastest growing sectors of the medical device market. Neuromodulation is a rapidly evolving medical technique that provides symptomatic relief through the alteration, or modulation, of nerve system function. It works by either stimulating nerves to produce a natural biological response or by applying small doses of pharmaceutical agents directly to the site of action.
The market has significant potential for growth with the increasing global burden of neurological and cardiovascular disorders, especially in the emerging economies. The growth in emerging markets such as India and China will be driven by an aging population that will increase demand for newer treatment options for age-related diseases. India’s expanding economy is likely to see an increased wealth among the population, specifically within the middle class, which will cause an increased adoption of westernised lifestyles. Diseases such as obesity and coronary heart disease will therefore become more prevalent. The neuromodulation devices market in the emerging economies will also benefit from a rise in demand for non-invasive treatment options and medical tourism. Growth in this market will also be driven by the approval and launch of neuromodulation devices that are more effective and involve a more simplified, less-invasive implantation procedure.
Neuromodulation Devices: World Market Prospects 2013-2023 analyses the top 4 companies involved in the neuromodulation devices market. This report also provides sales forecasts, market share analyses, discussions of technological developments and analyses of commercial drivers and restraints, including SWOT analysis of the overall neuromodulation devices market. There are 75 tables and figures included. The result is comprehensive profiles on the leading companies operating in the neuromodulation devices market with detailed analyses and informed opinion to benefit your work. Visiongain has determined that the value of the global Neuromodulation Devices Market will reach $12.45bn in 2023.
What makes this report unique?
Visiongain consulted widely with industry experts and full transcripts from these exclusive interviews are included in the report. As such, our reports have a unique blend of primary and secondary sources providing informed opinion. The report provides insight into key drivers and restraints facing the industry, as well as identifying leading companies. The report also provides a unique blend of qualitative analysis combined with extensive quantitative data including global, submarket and national market forecasts from 2012-2023 – all highlighting key business opportunities.
Why you should buy Neuromodulation Devices: World Market Prospects 2013-2023
• 111 pages of comprehensive analysis
• 2 Exclusive Visiongain interviews with experts from-
– Cochlear Ltd
– a US-based Medical Device Company (views provided anonymously)
• 75 tables, charts, and graphs
• Neuromodulation Device market forecasts between 2012-2023
• 3 Neuromodulation Device submarket forecasts from 2012-2023
– Spinal Cord Stimulation (SCS)
– Deep Brain Stimulation (DBS)
– Vagus Nerve Stimulation (VNS)
• A SWOT analysis
• Several leading companies identified and 4 profiled –
– St. Jude Medical
– Boston Scientific
You can order this report today
Gain an understanding of the overall neuromodulation devices market and the leading companies operating in this market by ordering Neuromodulation Devices: World Market Prospects 2013-2023.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
To view free sample pages of this report please click here